Hydromer Inc. Stock Analysis HYDI
Hydromer, Inc. is a polymer research and development company, which focuses on biotechnology and engages in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer-based products and services. The company is headquartered in Concord, North Carolina. The firm manages numerous global B2B services such as the sale of coating formulations, custom coating services, R&D, analytical testing, technology transfer, and dedicated machinery building, installation, and support. Its products include medical device coatings, industrial coatings, and Sea-Slide. Its medical device coatings include thromboresistant coatings, one-step coatings, cell-growth enhancing coatings, and primers. The company offers contract coating services using its own hydrophilic coating formulas, including its HydrUV UV coatings. The firm has developed value-added solutions to serve businesses in domestic and international markets in a range of industries. The firm's customers are located across the United States, Europe ,and Asia-Pacific.
Read More Hydromer Inc (HYDI) Chart
Key Statistics of Hydromer Inc (HYDI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.25Volume
142.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1.19MAvg. Volume
1847.86Dividend Yield
-Financial Metrics & Statements of Hydromer Inc (HYDI)
FAQ's for Hydromer Inc (HYDI)
- According to Musaffa’s Shariah screening methodology, Hydromer Inc (HYDI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.